For people already managing type 2 diabetes, the existing oral semaglutide Rybelsus (at lower doses of 714 mg, prescribed specifically for T2D) has a well-established track record on HbA1c reduction
Fasting triggers a cascade of metabolic benefits, including: Increased insulin sensitivity Enhanced GLP-1 secretion Reduced appetite and cravings Improved fat burning Studies show that even short fastslike a 12- to 16-hour fasting windowcan elevate GLP-1 and improve metabolic flexibility
References FDA Prescribing Information Wegovy, Ozempic, Rybelsus NEJM STEP, SUSTAIN, and SELECT trial publications MedlinePlus semaglutide FDA statements on compounded semaglutide and dosing-error reports Disclaimer Although the information on this page is based on available educational research and product information, it is provided for informational purposes only and is not medical advice
Cash prices sourced from GoodRx, May 2026, and represent estimates for 30-day supply at major Texas pharmacies